Guidance on

FDA Pre-submission

The FDA CDRH Pre-submission is a great way to get early feedback about future product submissions. We've outlined some tips to help you through the process. 

Pre-submission Benefits

The FDA CDRH Pre-Submission, or Pre-sub, is a type of Q-Submission that provides manufacturers an opportunity to communicate with the FDA about their planned product submissions. A Pre-sub allows you to have a meeting with the FDA to discuss your plan. Some benefits to the Pre-Sub:

  • These meetings may be very beneficial when preparing a submission for a new device that does not clearly fall within an established regulatory pathway.

  • These meetings may be very beneficial prior to initiating long term preclinical studies.

  • These meetings may be beneficial when planning a study that does not require an IDE i.e. studies outside of US or exempt or non-significant risk (NSR) devices.

  • These meetings may be beneficial before the submission to discuss non-clinical data and clinical study design

  • These meetings may be beneficial before submission of a marketing application. As the manufacturer, you can apprise the FDA review team on specifics of the device and clinical study data if there have been changes since initiation of an IDE, obtain feedback on preferred data presentation, or gain insight into the potential hurdles for approval or clearance.

  • and many more...

Pre-submission Content

The following documents and information should be part of your FDA Pre-submission:

  • Cover letter that includes the following information:

    • ​Designation of meeting request type aka Q-Sub type i.e. Pre-sub, 

    • Manufacturer name & contact information

    • Product Name

  • Pre-Submission package* - DOWNLOAD OUR TEMPLATE HERE

    • Purpose

    • Regulatory History

    • Planned Follow-on Submission

    • Background Information

    • Device Description

    • Proposed Predicate Devices (if applicable)

    • Intended Use/Indications for Use Statement

    • Description of How the Device is Planned to be Used

    • Risk Anaylsis

    • Discussion of Relevant Prior Information

    • Proposed Study Design

    • Specific Questions

    • Meeting Attendees

    • Proposed Meeting Dates (unless written feedback is requested). 

*Reference the latest FDA Guidance on Q-subs and Pre-submission requirements here. Note - the FDA frequently updates their websites and guidances. As of October 2019, the guidance is only a draft guidance and may change in the future. 

Other Pre-sub Requirements

Here are some additional requirements as it relates to your FDA Pre-submission:

  • 1 eCopy and 1 hard-copy are required to be submitted

  • An electronic copy (eCopy) is defined as an exact duplicate of the paper submission, created and submitted on a compact disc (CD), digital video disc (DVD), or a flash drive. Check out the latest guidance from FDA on eCopy requirements here.

  • An eCopy is accompanied by a paper copy of the signed cover letter and the complete paper submission.

  • The cover letter signature may be a wet (i.e., ink) signature or a valid digital signature

Mail Pre-sub to the following address:

Food and Drug Administration

Center for Devices and Radiological Health

Document Control Center – WO66-G609

10903 New Hampshire Ave.

Silver Spring, MD 20993-0002

Pre-submission Process

Here is an outline of the FDA Pre-submission process:

  1. Sponsor submits to the Document Control Center (see mailing address above)

  2. FDA conducts acceptance review (14 days)

  3. Meeting/Teleconference requested:

    1. FDA works with manufacturer to schedule the meeting/teleconference (21 days)

    2. FDA provides preliminary feedback via email (at least one week prior to the meeting/teleconference)

  4. FDA provides feedback (70 days)

  5. After Meeting/Teleconference held:

    1. Manufacturer provides draft minutes to Document Control Center (15 days)

    2. FDA reviews/edits minutes (30 days)

Summary

The FDA Pre-submission process is a great way to get early feedback and agreement from the FDA on your planned product development and potential clinical study efforts. 

We recognize you may still have a lot of questions. Do not hesitate to reach out to learn more about how we can help. 

Download our pre-submission template HERE

Need Help?

If you'd like to learn more about how we can help with your FDA Pre-submission efforts, please reach out. 

©2017-2019 RAC MEDICAL CONSULTING, LLC